Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Peer Christiansen"'
Autor:
Stephen Hamilton-Dutoit, Maret L. Maliniak, Henrik Toft Sørensen, Kristina B. Christensen, Per Damkier, Peer Christiansen, Timothy L. Lash, Lindsay J Collin, Sinna Pilgaard Ulrichsen, Deirdre Cronin-Fenton, Rami Yacoub, Thomas P. Ahern
Publikováno v:
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast cancer research : BCR, vol. 23, no. 1, pp. 103 . https://doi.org/10.1186/s13058-021-01480-1
Breast Cancer Research : BCR
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast Cancer Research, vol. 23, no. 1, 103 . https://doi.org/10.1186/s13058-021-01480-1
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast Cancer Research, vol. 23, 103 . https://doi.org/10.1186/s13058-021-01480-1
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)
Breast Cancer Research : BCR
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast Cancer Research, vol. 23, no. 1, 103 . https://doi.org/10.1186/s13058-021-01480-1
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast Cancer Research, vol. 23, 103 . https://doi.org/10.1186/s13058-021-01480-1
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)
Background Hypoxia-inducible factor-1α (HIF-1α) is a transcription factor that facilitates the adaptation of cancer cells to hypoxic conditions and may be prognostic of breast cancer recurrence. We evaluated the association of HIF-1α expression wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9e39bc949916f4137cca5c5dfff01a5
https://pure.au.dk/portal/da/publications/hypoxiainducible-factor1-expression-and-breast-cancer-recurrence-in-a-danish-populationbased-case-control-study(68e72280-51af-4af2-8ec1-638d84a3abdc).html
https://pure.au.dk/portal/da/publications/hypoxiainducible-factor1-expression-and-breast-cancer-recurrence-in-a-danish-populationbased-case-control-study(68e72280-51af-4af2-8ec1-638d84a3abdc).html
Autor:
Søren Feddersen, Cathrine Bredal Lythjohan, Thomas P. Ahern, Deirdre Cronin-Fenton, Anders Kjærsgaard, Peer Christiansen, Timothy L. Lash, Bent Ejlertsen, Per Damkier, Stephen Hamilton-Dutoit
Publikováno v:
Ahern, T P, Damkier, P, Feddersen, S, Kjærsgaard, A, Lash, T L, Hamilton-Dutoit, S, Lythjohan, C B, Ejlertsen, B, Christiansen, P M & Cronin-Fenton, D P 2020, ' Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin ', Acta Oncologica, vol. 59, no. 9, pp. 1009-1015 . https://doi.org/10.1080/0284186X.2020.1759820
Acta Oncol
Acta Oncol
Background: Statins treat hyperlipidemia and prevent cardiovascular morbidity and mortality. Evidence suggests that they also have anti-neoplastic activity. Several studies show a reduced rate of breast cancer recurrence among lipophilic statin users
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7599fe9f231f4b44d03ae47875a0159e
https://pure.au.dk/portal/da/publications/predictive-pharmacogenetic-biomarkers-for-breast-cancer-recurrence-prevention-by-simvastatin(7c8b40dd-4ca1-411d-acd7-29ae79244b9e).html
https://pure.au.dk/portal/da/publications/predictive-pharmacogenetic-biomarkers-for-breast-cancer-recurrence-prevention-by-simvastatin(7c8b40dd-4ca1-411d-acd7-29ae79244b9e).html
Autor:
Trine Tramm, Stephen Hamilton-Dutoit, James W. Baurley, Kristina Lystlund Lauridsen, Per Damkier, Anders Kjærsgaard, Peer Christiansen, Lindsay J Collin, Kristina B. Christensen, Maret L. Maliniak, Rebecca A. Silliman, Deirdre Cronin-Fenton, Timothy L. Lash, Michael E. Zwick, Thomas P. Ahern, Bent Ejlertsen, R. Benjamin Isett, Rebecca Nash, Henrik Toft Sørensen
Publikováno v:
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K, Silliman, R A, Toft Sørensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin-Fenton, D 2020, ' Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer Patients ', Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Background: Tamoxifen and its metabolites compete with estrogen to occupy the estrogen receptor. The conventional dose of adjuvant tamoxifen overwhelms estrogen in this competition, reducing breast cancer recurrence risk by nearly half. Phase I metab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1801d69fb5cd7b94c2ec62c58bf25321
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
Autor:
Sinna Pilgaard Ulrichsen, Henrik Toft Sørensen, Lauren E. McCullough, Michael Goodman, Kristina B. Christensen, Kristina Lystlund Lauridsen, Per Damkier, Rami Yacoub, Lance A. Waller, Timothy L. Lash, Thomas P. Ahern, Bent Ejlertsen, Deirdre Cronin-Fenton, Peer Christiansen, Lindsay J Collin, Stephen Hamilton-Dutoit
Publikováno v:
Collin, L J, Ulrichsen, S P, Ahern, T P, Goodman, M, McCullough, L E, Waller, L A, Bang Christensen, K, Damkier, P, Hamilton-Dutoit, S, Lauridsen, K L, Yacoub, R, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Cronin-Fenton, D P & Lash, T L 2020, ' 17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence : a Danish population-based study ', Acta Oncologica, vol. 59, no. 3, pp. 329-333 . https://doi.org/10.1080/0284186X.2019.1684560
Acta Oncol
Acta Oncol
BACKGROUND: Approximately 20–40% of patients diagnosed with breast cancer will experience a recurrence up to 20 years after their original diagnosis. 17?-hydroxysteroid dehydrogenase 1 and 2 (HSD17B1 and HSD17B2, respectively) regulate intratumoral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b1221ea8ab1bf3d1024c9bb6d4f0751
https://portal.findresearcher.sdu.dk/da/publications/2ac08303-0b6f-4061-acbe-e409048b9d9c
https://portal.findresearcher.sdu.dk/da/publications/2ac08303-0b6f-4061-acbe-e409048b9d9c
Autor:
Maj-Britt Jensen, Bo Grundtmann, Peer Christiansen, Anne Vibeke Lænkholm, Tove Filtenborg Tvedskov, Ann Knoop, Signe Korsgaard Skriver, Birgitte Bruun Rasmussen, Jürgen Handler, Bent Ejlertsen
Publikováno v:
Skriver, S K, Laenkholm, A-V, Rasmussen, B B, Handler, J, Grundtmann, B, Tvedskov, T F, Christiansen, P, Knoop, A S, Jensen, M-B & Ejlertsen, B 2018, ' Neoadjuvant letrozole for postmenopausal estrogen receptor-positive, HER2-negative breast cancer patients, a study from the Danish Breast Cancer Cooperative Group (DBCG) ', Acta Oncologica, vol. 57, pp. 1-7 . https://doi.org/10.1080/0284186X.2017.1401228
INTRODUCTION: Neoadjuvant endocrine treatment (NET) is a low-toxicity approach to achieve operability in locally advanced breast cancer, and to facilitate breast conservation in early breast cancer, particular in patients with highly estrogen recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04cf3ecf5be74027a71b12f95d3263aa
https://pure.au.dk/portal/da/publications/neoadjuvant-letrozole-for-postmenopausal-estrogen-receptorpositive-her2negative-breast-cancer-patients-a-study-from-the-danish-breast-cancer-cooperative-group-dbcg(00e87aba-9155-43c4-aa58-bd0b14890dc5).html
https://pure.au.dk/portal/da/publications/neoadjuvant-letrozole-for-postmenopausal-estrogen-receptorpositive-her2negative-breast-cancer-patients-a-study-from-the-danish-breast-cancer-cooperative-group-dbcg(00e87aba-9155-43c4-aa58-bd0b14890dc5).html
Autor:
Mette Nørgaard, Anne Marie L. Thomsen, Nickolaj R. Kristensen, Bjarne Kuno Møller, Deirdre Cronin-Fenton, Alma B Pedersen, Peer Christiansen, Christian Erikstrup
Publikováno v:
Breast Cancer Research : BCR
Thomsen, A M L, Pedersen, A B, Kristensen, N R, Møller, B K, Erikstrup, C, Christiansen, P M, Nørgaard, M & Cronin-Fenton, D 2017, ' Use of prescription drugs and risk of postoperative red blood cell transfusion in breast cancer patients : a Danish population-based cohort study ', Breast Cancer Research (Online Edition), vol. 19, no. 1, pp. 135 . https://doi.org/10.1186/s13058-017-0926-2
Breast Cancer Research, Vol 19, Iss 1, Pp 1-8 (2017)
Thomsen, A M L, Pedersen, A B, Kristensen, N R, Møller, B K, Erikstrup, C, Christiansen, P M, Nørgaard, M & Cronin-Fenton, D 2017, ' Use of prescription drugs and risk of postoperative red blood cell transfusion in breast cancer patients : a Danish population-based cohort study ', Breast Cancer Research (Online Edition), vol. 19, no. 1, pp. 135 . https://doi.org/10.1186/s13058-017-0926-2
Breast Cancer Research, Vol 19, Iss 1, Pp 1-8 (2017)
Background Several frequently used prescription drugs may affect bleeding risk. We investigated use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), selective serotonin reuptake inhibitors (SSRIs), and statins and risk of postoperative red
Autor:
Bent Ejlertsen, Thomas P. Ahern, Uffe Heide-Jørgensen, Peer Christiansen, Deirdre P. Cronin-Fenton, Timothy L. Lash, Henrik Toft Sørensen
Publikováno v:
Cronin-Fenton, D P, Heide-Jørgensen, U, Ahern, T P, Lash, T L, Christiansen, P, Ejlertsen, B & Sørensen, H T 2016, ' Low-dose aspirin, non-steroidal anti-inflammatory drugs, selective COX-2 inhibitors and breast cancer recurrence ', Epidemiology . https://doi.org/10.1097/EDE.0000000000000480
BACKGROUND: Aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), and selective COX-2 inhibitors may improve outcomes in breast cancer patients. We investigated the association of aspirin, NSAIDs, and use of selective COX-2 inhibitors with breast
Autor:
Deirdre P. Cronin-Fenton, Anders Kjærsgaard, Peer Christiansen, Lindsay J Collin, Stephen Hamilton-Dutoit, Bent Ejlertsen, Timothy L. Lash, Henrik Toft Sørensen, Thomas P. Ahern, Per Damkier, Rebecca A. Silliman
Publikováno v:
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christiansen, P M, Damkier, P, Ejlertsen, B, Hamilton-Dutoit, S, Kjærsgaard, A, Silliman, R A, Sørensen, H T & Lash, T L 2018, ' Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark ', BMJ Open, vol. 8, no. 7, e021805, pp. e021805 . https://doi.org/10.1136/bmjopen-2018-021805
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christiansen, P M, Damkier, P, Ejlertsen, B, Hamilton-Dutoit, S, Kjærsgaard, A, Silliman, R A, Sørensen, H T & Lash, T L 2018, ' Cohort Profile : The Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark ', BMJ Open, vol. 8, no. 7, e021805 . https://doi.org/10.1136/bmjopen-2018-021805
BMJ Open
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christiansen, P M, Damkier, P, Ejlertsen, B, Hamilton-Dutoit, S, Kjærsgaard, A, Silliman, R A, Sørensen, H T & Lash, T L 2018, ' Cohort Profile : The Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark ', BMJ Open, vol. 8, no. 7, e021805 . https://doi.org/10.1136/bmjopen-2018-021805
BMJ Open
PurposeThe Predictors of Breast Cancer Recurrence (ProBe CaRe) study was established to evaluate modification of tamoxifen (TAM) effectiveness in premenopausal women through reduced activity of TAM-metabolising enzymes. It comprehensively evaluates t
Autor:
Gitte Vrelits Sørensen, Peer Christiansen, Patricia A. Ganz, Lars Pedersen, Deirdre Cronin-Fenton, Henrik Toft Sørensen, Timothy L. Lash, Thomas P. Ahern, Steven W. Cole, Jens Peter Garne
Publikováno v:
Sørensen, G V, Ganz, P A, Cole, S W, Pedersen, L, Sørensen, H T, Cronin-Fenton, D, Garne, J P, Christiansen, P M, Lash, T & Ahern, T P 2013, ' Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence : A Danish Nationwide Prospective Cohort Study ', Journal of Clinical Oncology . https://doi.org/10.1200/JCO.2012.43.9190
Sørensen, G V, Ganz, P A, Cole, S W, Pedersen, L A, Sørensen, H T, Cronin-Fenton, D, Garne, J P, Christiansen, P M, Lash, T & Ahern, T P 2013, ' Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence : A Danish Nationwide Prospective Cohort Study ', Journal of Clinical Oncology, vol. 31, no. 18, pp. 2265-72 . https://doi.org/10.1200/JCO.2012.43.9190
Sørensen, G V, Ganz, P A, Cole, S W, Pedersen, L A, Sørensen, H T, Cronin-Fenton, D, Garne, J P, Christiansen, P M, Lash, T & Ahern, T P 2013, ' Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence : A Danish Nationwide Prospective Cohort Study ', Journal of Clinical Oncology, vol. 31, no. 18, pp. 2265-72 . https://doi.org/10.1200/JCO.2012.43.9190
Purpose To estimate associations between use of β-blockers, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers (ARBs) and breast cancer recurrence in a large Danish cohort. Patients and Methods We enrolled 18,733 women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee2acce864f79e3295e918c002864c5a
https://pure.au.dk/portal/da/publications/use-of-blockers-angiotensinconverting-enzyme-inhibitors-angiotensin-ii-receptor-blockers-and-risk-of-breast-cancer-recurrence(0d006b08-814d-499c-8bcc-1c8bd055549d).html
https://pure.au.dk/portal/da/publications/use-of-blockers-angiotensinconverting-enzyme-inhibitors-angiotensin-ii-receptor-blockers-and-risk-of-breast-cancer-recurrence(0d006b08-814d-499c-8bcc-1c8bd055549d).html
Publikováno v:
Vestergaard, P, Fischer, L, Mele, M, Mosekilde, L & Christiansen, P 2011, ' Use of bisphosphonates and risk of breast cancer ', Calcified Tissue International, vol. 88, no. 4, pp. 255-62 . https://doi.org/10.1007/s00223-011-9463-7
A decreased risk of breast cancer has been reported among patients given bisphosphonates. The present aims were to study potential associations between different antiosteoporosis drugs, including bisphosphonates, and the risk of breast cancer before
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::304ccc4ce2d26fa1260870fd59238388
https://pure.au.dk/portal/da/publications/use-of-bisphosphonates-and-risk-of-breast-cancer(68122498-da7d-4afa-8132-00de60340b8f).html
https://pure.au.dk/portal/da/publications/use-of-bisphosphonates-and-risk-of-breast-cancer(68122498-da7d-4afa-8132-00de60340b8f).html